17. Poveda A, et al. Gynecol Oncol. 2022 Mar;164(3):498-504. 18. Gao Q, et al. Clin Cancer Res. 2022 Jun 1;28(11):2278-2285. 19. NCCN Guidelines Version 2.2023 Ovarian Cancer. 20. Berek JS, et al. A...
参考文献: González-Martín A, Harter P, Leary A, Lorusso D, Miller RE, Pothuri B, Ray-Coquard I, Tan DSP, Bellet E, Oaknin A, Ledermann JA; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Pra...
19. NCCN Guidelines Version 2.2023 Ovarian Cancer. 20. Berek JS, et al. Ann Oncol. 2018 Aug 1;29(8):1784-1792. 21. Wu XH, et al. Ann Oncol. 2021 Apr;32(4):512-521. 22. X. Wu, et al. ESMO Open, Volume 8, Issue 1, Supplement 1, 2023. 声明:本文仅供医疗卫生专业人士为了解...
9.Monk BJ, et al. J Clin Oncol 40, 2022 (suppl 17; abstr LBA5500). 10.X Wu, et al. ESMO 2023. Abstract LBA36. 11.温灏,等.中国实用妇科与产科杂志, 2022, 38(1):56-65. 12.NCCN ClinicalPractice Guidelines in Oncolo...
12.NCCN ClinicalPractice Guidelines in Oncology. Ovarian Cancer, Version 2. 2023. 13.Konstantinopoulos PA, et al. J Clin Oncol. 2020 Apr 10;38(11):1222-1245. 14.《基于下一代测序技术的BRCA1/2基因检测指南(2019版)》编写组. 中华病理学杂志, 2019, 48(9):670-677. ...
NCCN Guidelines for treatment of ovarian cancer, 2023 V2[EB/OL]. [2023-11- 15]. https://www.nccn.org. [16] 中国抗癌协会妇科肿瘤专业委员会,中国抗癌协会肿瘤多 学科诊疗(MDT)专业委员会,中国医师协会肿瘤多学科 诊疗专业委员会. 妇科恶性肿瘤多学科诊疗中国专家共识 (2022年版)[J]. 中国癌症杂志,...
ESMO2023新诊断和复发性卵巢癌的诊断、治疗和随访.pdf,ESMO2023 新诊断和复发性卵巢癌的诊断、治疗和随访 欧洲肿瘤内科学会(ESMO)是欧洲最负盛名的肿瘤学术平台,ESMO 指南是临床工作者的重要参考。ESMO 卵巢癌指南于 2013 年发布, 此后,仅在 2021年对一线治疗推荐进行了
Running header: ESMO Clinical Practice Guidelines for risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes Word count: 10,014 (excluding title page, acknowledgements, funding and disclosure sections; tables are counted as 150 words); References: 120; Tables: 1; Figures...
Non-epithelial ovarian cancer: ESMO Clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol, 23, 20-6.Colombo N, Peiretti M, Garbi A, et al. Non-epithelial ovari- an cancer: ESMO Clinical Practice Guidelines for diagnoz sis, treatment and follow-up [ J ]. Ann ...
[9] Paluch-Shimon S, Cardoso F, Partridge AH, et al. ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5). Ann Oncol. 2022 Nov;33(11):1097-1118. [10] Baek SY, Noh WC, Ahn SH, et al. Adding Ovarian Suppression to Tamoxifen for Premenopausal Women...